CareCloud Performance degli utili passati
Criteri Il passato verificati 5/6
CareCloud ha registrato una crescita degli utili a un tasso medio annuo di 11.8%, mentre il settore Healthcare Services ha registrato utili in crescita a un tasso medio annuo di 21.8%. I ricavi sono stati in diminuzione a un tasso medio annuo di 4.3%. Il ritorno sul capitale proprio di CareCloud è 45.9% e ha margini netti di 2.3%.
Informazioni chiave
11.80%
Tasso di crescita degli utili
11.90%
Tasso di crescita dell'EPS
| Healthcare Services Crescita del settore | 1.72% |
| Tasso di crescita dei ricavi | -4.30% |
| Rendimento del capitale proprio | 45.93% |
| Margine netto | 2.30% |
| Ultimo aggiornamento sugli utili | 30 Jun 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Articolo di analisi • Aug 09
CareCloud, Inc. (NASDAQ:CCLD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
It's been a good week for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, because the company has just released its...
Aggiornamento narrativa • Jul 01
CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion
Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.
Aggiornamento narrativa • Jun 16
CCLD: Balance Sheet Reshaping And 2026 Guidance Will Support Bullish Repricing
Analysts have adjusted their price target on CareCloud to $8.00, reflecting updated assumptions around revenue growth, profit margins, discount rate and future P/E that they consider better aligned with the company’s current outlook. What’s in the News for CareCloud CareCloud fully redeemed all outstanding 8.75% Series B Preferred Stock, funded with a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank.Aggiornamento narrativa • Jun 02
CCLD: Capital Reshaping And 2026 Outlook Will Clarify Underlying Revenue Trends
Analysts have reduced their price target on CareCloud to $3.25, citing concern that recent acquisitions, including plans to acquire an aircraft for client visits, may be obscuring underlying revenue declines. What's in the News CareCloud redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank, as part of a multi year capital structure shift.Aggiornamento narrativa • May 13
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.Articolo di analisi • May 11
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...
Aggiornamento narrativa • Apr 29
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.Aggiornamento narrativa • Apr 14
CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.Aggiornamento narrativa • Mar 31
CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.Aggiornamento narrativa • Mar 17
CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.Aggiornamento narrativa • Mar 02
CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.Aggiornamento narrativa • Feb 16
CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.Articolo di analisi • Feb 04
Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...Aggiornamento narrativa • Feb 02
CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.Seeking Alpha • Jan 29
CareCloud: Undervalued AI Play In Healthcare IT
Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking AlphaAggiornamento narrativa • Jan 19
CCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.Aggiornamento narrativa • Jan 05
CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.Aggiornamento narrativa • Dec 15
CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.Aggiornamento narrativa • Dec 01
CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.Aggiornamento narrativa • Nov 17
CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.Articolo di analisi • Aug 26
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...Articolo di analisi • May 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...
Nuova narrativa • Apr 12
CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.Articolo di analisi • Mar 16
Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...Articolo di analisi • Mar 13
Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...Articolo di analisi • Feb 19
CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Articolo di analisi • Jan 18
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...Articolo di analisi • Nov 13
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...Articolo di analisi • Oct 07
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Aug 31
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Articolo di analisi • Jul 13
CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...Articolo di analisi • Jun 27
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • May 22
CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...Articolo di analisi • Mar 22
CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...Articolo di analisi • Mar 22
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Articolo di analisi • Feb 02
Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...Articolo di analisi • Jan 30
Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Articolo di analisi • Dec 19
CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Articolo di analisi • Sep 28
Is CareCloud (NASDAQ:CCLD) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Ripartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come CareCloud guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 26 | 129 | 3 | 26 | 9 |
| 31 Mar 26 | 124 | 4 | 25 | 8 |
| 31 Dec 25 | 120 | 4 | 23 | 6 |
| 30 Sep 25 | 114 | 2 | 22 | 5 |
| 30 Jun 25 | 112 | 0 | 22 | 4 |
| 31 Mar 25 | 113 | -4 | 22 | 4 |
| 31 Dec 24 | 111 | -4 | 22 | 4 |
| 30 Sep 24 | 111 | -52 | 24 | 4 |
| 30 Jun 24 | 112 | -58 | 26 | 4 |
| 31 Mar 24 | 113 | -62 | 29 | 5 |
| 31 Dec 23 | 117 | -64 | 31 | 5 |
| 30 Sep 23 | 121 | -20 | 32 | 5 |
| 30 Jun 23 | 126 | -16 | 33 | 5 |
| 31 Mar 23 | 133 | -12 | 33 | 4 |
| 31 Dec 22 | 139 | -10 | 34 | 4 |
| 30 Sep 22 | 144 | -7 | 34 | 3 |
| 30 Jun 22 | 148 | -6 | 34 | 3 |
| 31 Mar 22 | 145 | -9 | 33 | 3 |
| 31 Dec 21 | 140 | -11 | 33 | 4 |
| 30 Sep 21 | 134 | -15 | 31 | 7 |
| 30 Jun 21 | 128 | -18 | 31 | 9 |
| 31 Mar 21 | 113 | -23 | 29 | 9 |
| 31 Dec 20 | 105 | -23 | 29 | 9 |
| 30 Sep 20 | 89 | -21 | 26 | 7 |
| 30 Jun 20 | 74 | -16 | 23 | 5 |
| 31 Mar 20 | 71 | -11 | 22 | 3 |
| 31 Dec 19 | 64 | -7 | 19 | 1 |
| 30 Sep 19 | 65 | -8 | 21 | 1 |
| 30 Jun 19 | 65 | -9 | 21 | 1 |
| 31 Mar 19 | 57 | -8 | 19 | 1 |
| 31 Dec 18 | 51 | -7 | 18 | 1 |
| 30 Sep 18 | 42 | -6 | 16 | 1 |
| 30 Jun 18 | 33 | -4 | 13 | 1 |
| 31 Mar 18 | 32 | -5 | 12 | 1 |
| 31 Dec 17 | 32 | -8 | 13 | 1 |
| 30 Sep 17 | 32 | -11 | 13 | 1 |
| 30 Jun 17 | 30 | -11 | 13 | 1 |
| 31 Mar 17 | 28 | -10 | 13 | 1 |
| 31 Dec 16 | 24 | -10 | 13 | 1 |
| 30 Sep 16 | 21 | -6 | 12 | 1 |
| 30 Jun 16 | 21 | -6 | 12 | 1 |
| 31 Mar 16 | 22 | -6 | 12 | 1 |
| 31 Dec 15 | 23 | -5 | 12 | 1 |
| 30 Sep 15 | 25 | -5 | 13 | 1 |
Guadagni di qualità: CCLD ha guadagni di alta qualità.
Margine di profitto in crescita: Gli attuali margini di profitto netti di CCLD (2.3%) CCLD sono più alti rispetto allo scorso anno (0.02%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: CCLD è diventata redditizia negli ultimi 5 anni, aumentando i guadagni del 11.8% all'anno.
Accelerare la crescita: La crescita degli utili di CCLD nell'ultimo anno ( 17288.2% ) supera la media quinquennale ( 11.8% all'anno).
Guadagni vs Settore: La crescita degli utili CCLD nell'ultimo anno ( 17288.2% ) ha superato la percentuale del settore Healthcare Services 14.8%.
Rendimento del capitale proprio
ROE elevato: Sebbene il Return on Equity ( 45.93% ) di CCLD sia eccezionale, questa metrica è distorta a causa del loro elevato livello di debito.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/09 17:20 |
| Prezzo dell'azione a fine giornata | 2026/09/09 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
CareCloud, Inc. è coperta da 8 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |